Lv5
1120 积分 2022-04-26 加入
Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non–Small Cell Lung Cancer Patients
13天前
已完结
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
13天前
已完结
The Integration of Radiotherapy with Immunotherapy for the Treatment of Non–Small Cell Lung Cancer
13天前
已完结
Combining Immunotherapy with Radiation Therapy in Non–Small Cell Lung Cancer
13天前
已关闭
Trial in progress: A phase 3, randomized, double-blind trial of trilaciclib versus placebo in patients receiving first- or second-line gemcitabine and carboplatin for locally advanced unresectable or metastatic triple-negative breast cancer (PRESERVE 2)
21天前
已关闭
[Research progress of immune checkpoint inhibitors in clinical diagnosis and treatment of non-small cell lung cancer]
1个月前
已完结
Clinical Implications of Exenatide as a Twice-Daily or Once-Weekly Therapy for Type 2 Diabetes
1个月前
已完结
Clinical Implications of Exenatide as a Twice-Daily or Once-Weekly Therapy for Type 2 Diabetes
1个月前
已关闭
Abstract CT099: BRIGHT-2 final analysis: A phase III trial of bireociclib plus fulvestrant as second-line endocrine therapy for patients with advanced HR+/HER2-breast cancer
1个月前
已关闭
Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity
2个月前
已完结
皖公网安备34019202002308
